STAT

APRIL 9, 2024

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with an update on the biotech market, a look at the future of genome editing, and the evolving definition of “insider trading.” ” Read the rest…

Vaccines 251

Vaccines Drug Pricing Drug Development 251

European Pharmaceutical Review

NOVEMBER 1, 2023

In July 2022, the World Health Organization (WHO) released its inaugural report on the pipeline of vaccines currently in development to prevent infections caused by antimicrobial resistance (AMR) bacterial pathogens. WHO referred to 61 bacterial vaccine candidates in diverse stages of clinical development.

Vaccines 98

Vaccines Immunity Immunization Drug Development 98

STAT

DECEMBER 20, 2023

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Today, we get into why Amy Abernethy is leaving Verily, and why the ongoing reckoning with AI doesn’t necessarily need the voice of Google to chime in.

Vaccines 352

Vaccines Drug Pricing Drug Development 352

PharmaTech

MARCH 28, 2024

Univercells and Altamira Therapeutics are collaborating on nanoparticle-delivered mRNA vaccines, while Andelyn Biosciences and Grace Science are partnering on novel therapies for NGLY1 deficiency.

Drug Development 52

Drug Development Vaccines 52

STAT

NOVEMBER 3, 2023

There’s potential that a stem cell infusion from kidney donors might help prevent organ rejection — allowing patients to perhaps wean from immunosuppressive drugs. Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox.

Vaccines 259

Vaccines Drug Pricing Drug Development 259

pharmaphorum

FEBRUARY 10, 2021

Given the large unmet clinical need in this oncology indication and aligned with recent clinical trial progress, the Triple Negative Breast Cancer (TNBC) Drug Development Digital Summi t has been created to provide insight into industry- and academic-led clinical programs developing immune checkpoint, DDR inhibitor, ADC and other novel agents.

Drug Development 109

Drug Development Immunity Immunization Vaccines 109

STAT

MARCH 25, 2024

We also examine how Covid-19 vaccine makers are faring today, and more. Today, we discuss the implications of the Supreme Court’s forthcoming mifepristone evaluation on the FDA and the biopharma industry. Read the rest…

Vaccines 227

Vaccines Drug Pricing Drug Development 227

pharmaphorum

JANUARY 31, 2022

It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Innovative new vaccines are being created more rapidly than ever before.

Vaccines 78

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 78

Pharmaceutical Business Review

AUGUST 28, 2023

These candidates are being developed to offer better protection, extend the duration in preventing illness and transmission, as compared to the current vaccine technologies. The study will compare the relative efficacy of next-generation vaccines against approved vaccines to prevent symptomatic, PCR-confirmed SARS-CoV-2 infection.

Vaccines 52

Vaccines Clinical Pharmacology Immunity Immunization 52

pharmaphorum

DECEMBER 6, 2022

Pfizer and partner BioNTech have launched a countersuit against Moderna in a patent despite centring on their mRNA-based vaccines for COVID-19. It also waived its rights to bring the lawsuit when it pledged not to sure other COVID-19 vaccine producers during the pandemic, according to Reuters.

Vaccines 79

Vaccines Immunity Immunization Drug Development 79

STAT

MARCH 14, 2024

A new study suggests the antiviral drug obeldesivir may be effective in curing Ebola Sudan infections, for which there are currently no approved vaccines or treatments.

Vaccines 359

Vaccines Drug Development 359

pharmaphorum

MARCH 10, 2022

With a tight lens on late translational through to phase II clinical progress; the 2nd Chronic HBV Drug Development Summit is dedicated to advancing direct antiviral and immunotherapy pipelines in combination therapy paradigms. The post Welcome to the 2nd Chronic HBV Drug Development Summit appeared first on.

Drug Development 52

Drug Development Immunity Immunization Vaccines 52

Outsourcing Pharma

FEBRUARY 18, 2021

With demand for fast-tracking therapies, vaccines and other products increasing, companies like Azzur Group offer the ability to add capabilities quickly.

Drug Development 98

Drug Development Vaccines 98

STAT

NOVEMBER 10, 2023

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Today we have two FDA approvals, preview late-breakers at this weekend’s American Heart Association scientific sessions, and offer up your very favorite podcast. Read the rest…

Vaccines 179

Vaccines Drug Development 179

STAT

NOVEMBER 10, 2022

Support for community vaccination campaigns has dwindled. government will stop paying for Covid vaccines and treatments, which could widen gaps in access as the products move to being covered by insurance. States are reporting outbreak data less frequently, and globally, testing and surveillance programs have been curtailed.

Vaccines 335

Vaccines Drug Development 335

STAT

MARCH 6, 2023

Still, when doctors told her last year that the cancer was growing despite two operations, radiation therapy, and a fifth regimen of chemotherapy, the retired business-meeting facilitator decided to do something unorthodox: spend $83,000 out of pocket on an unproven experimental cancer vaccine.

Vaccines 237

Vaccines Bioethics Immunity Immunization 237

STAT

DECEMBER 8, 2023

Today, we talk about the much-awaited CRISPR-based drug Casgevy, discuss the new Gavi initiative that plans to dramatically ramp up vaccine manufacturing in Africa, and more.   Sign up  to get our biotech newsletter in your inbox. Have a nice weekend! Read the rest…

Vaccines 218

Vaccines Drug Pricing Drug Development 218

STAT

FEBRUARY 13, 2024

Today, some amazing intel on Merck’s Ebola vaccine: Turns out, it can reduce risk of death, even after a person has been infected. Also, investors bet on another obesity drug — this time from BioAge, which is combining Zepbound with a pill that keeps muscle wasting at bay. It’s Meghana.

Vaccines 204

Vaccines Drug Pricing Drug Development 204

STAT

APRIL 3, 2024

LONDON — Moderna may be best known for its Covid-19 vaccine, but since its start, it’s always been set on developing therapies. But the company’s vision of making cells into their own drug factories is showing signs of progress.

Vaccines 306

Vaccines Drug Development 306

pharmaphorum

APRIL 8, 2021

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . BioNTech seeks “new kind of pharma company”.

Drug Development 80

Drug Development Vaccines Documentation Communication 80

STAT

JUNE 21, 2023

After all, it opens the door for Medicare to negotiate the price of small-molecule drugs after nine years on the market (as opposed to 13 years for biologic drugs like vaccines, cell therapies, or gene therapies). But the law hasn’t brought a total halt to all such drug development — at least, not yet.

Vaccines 174

Vaccines Drug Development 174

STAT

JANUARY 16, 2024

Today, we talk a lot about regulatory policy — for flu vaccines and for physicians.   Sign up  to get our biotech newsletter in your inbox. Hope you had a restful and reflective long weekend.

Vaccines 211

Vaccines Drug Pricing Drug Development 211

STAT

FEBRUARY 22, 2024

Damian here with an update on the plight of the  other  Covid-19 vaccine company, Wall Street’s latest GLP-1 trade, and the quest for a universal antivenom. Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Hello, all.

Vaccines 209

Vaccines Drug Pricing Drug Development 209

pharmaphorum

MARCH 30, 2022

CureVac and GlaxoSmithKline’s first attempt to develop a COVID-19 vaccine was a salutary reminder of the pitfalls in drug development, as the mRNA shot crashed and burned in a clinical trial last year, but they aren’t giving up.

Vaccines 63

Vaccines Immunity Immunization Drug Development 63

STAT

JANUARY 9, 2023

The vaccine maker Novavax, which has faced several years of dramatic ups and downs around the development of its Covid-19 vaccine, announced Monday that its CEO of more than 11 years, Stanley Erck, would be stepping down. Investors had not been expecting the departure, but cheered the news.

Vaccines 204

Vaccines Drug Development 204

Pharmaceutical Technology

JUNE 10, 2023

Influenza vaccine 2 is under clinical development by Shanghai Institute of Biological Products and currently in Phase I for Pandemic Influenza. According to GlobalData, Phase I drugs for Pandemic Influenza does not have sufficient historical data to build an indication benchmark PTSR for Phase I. Buy the report here.

Vaccines 40

Vaccines Immunity Immunization Hospitals 40

Pharmaceutical Technology

JUNE 10, 2023

Influenza vaccine 2 is under clinical development by Shanghai Institute of Biological Products and currently in Phase I for Pandemic Influenza. According to GlobalData, Phase I drugs for Pandemic Influenza does not have sufficient historical data to build an indication benchmark PTSR for Phase I. Buy the report here.

Vaccines 40

Vaccines Immunity Immunization Hospitals 40

STAT

AUGUST 25, 2023

Good morning Pharmalittle students. This is Allison DeAngelis, filling in for Ed Silverman while he’s away from the Pharmalot campus. I debated assigning you a “What I did on my summer vacation” essay to write over the weekend. Instead, we’re going to discuss the latest healthcare news!

Vaccines 188

Vaccines Drug Development 188

Pharmafile

MARCH 15, 2023

Turku, Finland – March 15, 2023 – DelSiTech Ltd, a Finnish drug delivery and drug development company, today announces that it has been awarded a grant from the Bill & Melinda Gates Foundation to develop long-acting injectable formulations ensuring the slow release of human immunodeficiency virus (HIV) vaccine.

Vaccines 40

Vaccines Drug Development 40

pharmaphorum

AUGUST 8, 2022

If confirmed, it will be another example of Pfizer leveraging the windfall cash generated by its COVID-19 vaccine Comirnaty and oral antiviral therapy Paxlovid to beef up its pipeline of new therapies, coming a few months after it closed a $6.7 The post Pfizer bid for sickle cell drug developer GBT said to be imminent appeared first on.

Drug Development 52

Drug Development Vaccines 52

PharmExec

DECEMBER 8, 2022

Our annual report spotlighting notable investments in new drug development captures a mix of gradual gains and giant leaps—both equally as promising—in five expanding and diverse therapeutic areas: spinal muscular atrophy, hemophilia A, intranasal and inhaled vaccines, gene-targeted therapy, and RNA therapeutics.

Vaccines 119

Vaccines Drug Development 119

STAT

NOVEMBER 13, 2023

We also learn about a new initiative to try and prevent gonorrhea spread with a meningitis vaccine. Lots of news on the cardiovascular front this morning: We discuss Novo Nordisk’s plans in heart disease, and Verve’s gene editing therapy for familial hypercholesterolemia. Read the rest…

Vaccines 223

Vaccines Drug Pricing Drug Development 223

Express Pharma

MARCH 7, 2024

Prior to that, he was the COO and Executive Director for Sanofi in Hyderabad, where he was responsible for initiating the manufacturing operation for injectable polio vaccine. The post Veeda Board appoints Dr Mahesh Bhalgat as Group CEO appeared first on Express Pharma.

Vaccines 91

Vaccines Drug Development 91

STAT

OCTOBER 10, 2023

The state’s biotech scene   exploded in the mid-2010s and early in the pandemic as exuberant investors disregarded the high failure rate in drug development and bet on buzzy technologies such as gene editing and messenger RNA vaccines. And although many companies are making layoffs, others are expanding.

Vaccines 318

Vaccines Generic Medicine Drug Development Packaging 318

pharmaphorum

OCTOBER 30, 2020

Moderna is still preparing for the launch of its COVID-19 vaccine mRNA-1273 – assuming phase 3 trials go to plan – but has already received $1.1 That is the basis for filing for emergency use authorisation (EUA) of the vaccine in the US, according to criteria set out by the FDA. billion in deposits for the shot.

Vaccines 74

Vaccines Immunity Immunization Drug Development 74

STAT

JANUARY 9, 2024

… GSK will purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead , STAT writes. The company has seen a successful launch of its RSV vaccine, which was approved last year.

Vaccines 203

Vaccines Drug Development 203

European Pharmaceutical Review

OCTOBER 30, 2023

Vaccitech’s Chief Business Officer, Graham Griffiths, discusses key learnings in drug and vaccine development , the challenges of preparing for the unknown, and how strategic collaboration is imperative to achieve faster and more equitable outcomes – if and when another pandemic strikes.

Vaccines 95

Vaccines Drug Development 95